Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro. (Q39550477)
Jump to navigation
Jump to search
scientific article published on 15 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro. |
scientific article published on 15 June 2011 |
Statements
Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro (English)
Rakesh K Singh
Lee Dorf
Angelica DeMartino
Sharon Illenye
Karen Koto
Erika A Currier
Takamaru Ashikaga
Kyu Kwang Kim
Giselle L Saulnier Sholler